BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal By Watertime - March 27, 2026 0 Post Content RELATED ARTICLESMORE FROM AUTHOR Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better than Traditional Antidepressants; Usona’s First Patent Application Publishes Esme Dark – Psychedelics, Somatics and the Shadow What Approval Won’t Solve: Brian Barnett on Ketamine’s Lessons, RVUs, and Scaling Psychedelic Care
